By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Lev Pharmaceuticals, Inc. 

Denver  Colorado    U.S.A.
Phone: n/a Fax:



Company News
ViroPharma Incorporated (VPHM) Completes Acquisition of Lev Pharmaceuticals, Inc. 10/22/2008 9:30:52 AM
Lev Pharmaceuticals, Inc.'s Cinryze(TM) Receives FDA Approval for Prophylaxis Against Hereditary Angioedema Attack 10/13/2008 6:44:49 AM
ViroPharma Incorporated (VPHM) and Lev Pharmaceuticals, Inc. Receive Hart-Scott-Rodino Clearance from The Federal Trade Commission 9/3/2008 10:36:41 AM
Lev Pharmaceuticals, Inc. Reports Second Quarter 2008 Financial Results 8/1/2008 8:15:09 AM
ViroPharma Incorporated (VPHM) to Acquire Lev Pharmaceuticals, Inc. for $442.9 Million; Will Recieve Additional $174.6 Million in Bonus Payments if Lev's Cinryze Drug Meets Regulatory and Sales Goals 7/15/2008 7:24:12 AM
Lev Pharmaceuticals, Inc. to Present at the Collins Stewart 4th Annual Growth Conference 7/2/2008 8:45:51 AM
Lev Pharmaceuticals, Inc. to Submit Cinryze™ Application to the European Medicines Evaluation Agency 7/1/2008 10:56:30 AM
Lev Pharmaceuticals, Inc. to Present at the Jefferies & Co. 2nd Annual Healthcare Conference 6/19/2008 9:49:43 AM
Lev Pharmaceuticals, Inc. to Present at the Needham & Co. 7th Annual Biotechnology and Medical Technology Conference 6/5/2008 9:17:07 AM
Lev Pharmaceuticals, Inc. Signs Agreements with CuraScript, CVS Caremark, and FFF Enterprises to Support Cinryze(TM) Commercialization 6/4/2008 11:03:54 AM